Navigation Links
New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced

CARMEL, Ind., Sept. 25 /PRNewswire/ -- Diabco Life Sciences, LLC, an Indiana based company, has introduced a new clinically tested nutraceutical product for consumers concerned about the growing health risks associated with diabetes. This new product, Diabatrol, is a nutrient dense, fiber and antioxidant-rich dietary supplement that has been scientifically proven to stabilize blood sugar spiking and reduce insulin resistance, two conditions that most often lead to Type II diabetes.

Diabetes Risk Rising in the U.S.

According to the American Diabetes Association and the Centers for Disease Control and Prevention, Americans are increasingly at risk for diabetes. Currently, an estimated 107 million individuals in the U.S. are at risk of diabetes or pre-diabetes. Diabetes is a complex disease that impacts many vital functions and organs in the human body. Diabetes can cause vascular and nerve damage, heart disease, increased risk for kidney failure, and blindness. Diabetes experts advise that preventative action, early detection and aggressive management of diabetes can greatly improve the chances for a long and healthy life without significant health complications.

Diabatrol's Role in Reducing Risk

By reducing insulin resistance, Diabatrol works to allow the body to properly utilize insulin and stabilize blood glucose imbalances naturally, thereby helping to reduce the health risks associated with diabetes. Diabatrol's active ingredients not only help promote healthy glucose metabolism, but also help reduce oxidative stress and insulin resistance, two key concerns for diabetics and pre-diabetics.

Diabatrol is a nutraceutical with all natural active ingredients, not a prescription pharmaceutical. Diabatrol is a fortified whole grain derivative that provides a broad nutritional approach to diabetes management. All active nutritional components in Diabatrol have been clinically tested and documented to be beneficial for Type II diabetics. Diabatrol is hypoallergenic, gluten free, low glycemic and contains more than 80 natural antioxidants. Packaged in easy to use single-serving packets, Diabatrol provides a proactive nutritional approach to blood glucose management that can be easily incorporated into a total healthy lifestyle and diabetes wellness program.

Clinical testing of Diabatrol's active ingredients yielded the following results: In a 60-day double-blind randomized trial, Type II diabetes test subjects taking Diabatrol realized a 32.9 percent (52 points) reduction in fasting blood glucose levels and an eight percent reduction in LDL (so-called "bad cholesterol") levels. These clinical tests were peer reviewed and published in the Journal of Nutritional Biochemistry and are more fully documented on the Diabco Life Sciences website at

The term nutraceuticals refers to foods that have proven medical or health benefits to help mitigate certain diseases. Diabatrol is among the first nutraceuticals that conform to the new guidelines established under the U.S. Dietary Supplements, Health and Education Act (DSHEA), which is overseen by the U.S. Food and Drug Administration. DSHEA was established by the federal government to regulate the nutritional supplements industry and provide consumers with reliable guidelines for evaluating claims made by makers of such products.

About Diabco Life Sciences, LLC

Diabco Life Sciences, LLC (Diabco) was established in 2003 to focus on diabetes and product research. Diabco's mission is to provide effective nutraceutical products for consumers seeking performance-proven natural alternatives to help manage their blood glucose metabolism and to reduce the health risks associated with Type II diabetes and pre-diabetes. Nutraceuticals are nutrient dense functional foods, "medical foods" by definition that have been tested and proven to help mitigate certain health risks. More information about Diabco can be found at or by writing to Diabco Life Sciences, 484 East Carmel Drive, #204, Carmel, Indiana, 46032.

SOURCE Diabco Life Sciences, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Drug stabilizes cancer growth
2. Recommendations for Treatment of Blood Pressue
3. Blood Cells Capable of Regenerating Liver
4. Infant receives first bloodless liver transplant
5. Spouses and other partners lower blood pressure says new research
6. H2O - a cure for low blood pressure
7. Uncontrolled blood pressure
8. Weight and Blood Pressure
9. Grandmother’s diet in pregnancy can affect grandchildren’s blood sugr
10. Early diagnosis for autism from blood tests may be possible
11. Antibiotic from crab blood indentified
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: